IBDEI14B ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40581,1,2,0)
 ;;=2^51705
 ;;^UTILITY(U,$J,358.3,40581,1,3,0)
 ;;=3^Change of Bladder Tube
 ;;^UTILITY(U,$J,358.3,40582,0)
 ;;=51715^^150^1974^9^^^^1
 ;;^UTILITY(U,$J,358.3,40582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40582,1,2,0)
 ;;=2^51715
 ;;^UTILITY(U,$J,358.3,40582,1,3,0)
 ;;=3^Endoscopic Inj w/ Implant
 ;;^UTILITY(U,$J,358.3,40583,0)
 ;;=53601^^150^1974^19^^^^1
 ;;^UTILITY(U,$J,358.3,40583,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40583,1,2,0)
 ;;=2^53601
 ;;^UTILITY(U,$J,358.3,40583,1,3,0)
 ;;=3^Urethral Dil,Subsequent
 ;;^UTILITY(U,$J,358.3,40584,0)
 ;;=53621^^150^1974^18^^^^1
 ;;^UTILITY(U,$J,358.3,40584,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40584,1,2,0)
 ;;=2^53621
 ;;^UTILITY(U,$J,358.3,40584,1,3,0)
 ;;=3^Urethral Dil,Stricture
 ;;^UTILITY(U,$J,358.3,40585,0)
 ;;=51725^^150^1975^5^^^^1
 ;;^UTILITY(U,$J,358.3,40585,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40585,1,2,0)
 ;;=2^51725
 ;;^UTILITY(U,$J,358.3,40585,1,3,0)
 ;;=3^CMG,Simple
 ;;^UTILITY(U,$J,358.3,40586,0)
 ;;=51726^^150^1975^4^^^^1
 ;;^UTILITY(U,$J,358.3,40586,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40586,1,2,0)
 ;;=2^51726
 ;;^UTILITY(U,$J,358.3,40586,1,3,0)
 ;;=3^CMG,Complex
 ;;^UTILITY(U,$J,358.3,40587,0)
 ;;=51797^^150^1975^8^^^^1
 ;;^UTILITY(U,$J,358.3,40587,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40587,1,2,0)
 ;;=2^51797
 ;;^UTILITY(U,$J,358.3,40587,1,3,0)
 ;;=3^Intra-Abdominal VP (Rectal)
 ;;^UTILITY(U,$J,358.3,40588,0)
 ;;=51785^^150^1975^6^^^^1
 ;;^UTILITY(U,$J,358.3,40588,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40588,1,2,0)
 ;;=2^51785
 ;;^UTILITY(U,$J,358.3,40588,1,3,0)
 ;;=3^EMG Needle
 ;;^UTILITY(U,$J,358.3,40589,0)
 ;;=51741^^150^1975^11^^^^1
 ;;^UTILITY(U,$J,358.3,40589,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40589,1,2,0)
 ;;=2^51741
 ;;^UTILITY(U,$J,358.3,40589,1,3,0)
 ;;=3^Uroflow,Complex
 ;;^UTILITY(U,$J,358.3,40590,0)
 ;;=51792^^150^1975^9^^^^1
 ;;^UTILITY(U,$J,358.3,40590,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40590,1,2,0)
 ;;=2^51792
 ;;^UTILITY(U,$J,358.3,40590,1,3,0)
 ;;=3^Stim Evoked Response (Bulbocavernous Reflex Latency Time)
 ;;^UTILITY(U,$J,358.3,40591,0)
 ;;=51798^^150^1975^10^^^^1
 ;;^UTILITY(U,$J,358.3,40591,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40591,1,2,0)
 ;;=2^51798
 ;;^UTILITY(U,$J,358.3,40591,1,3,0)
 ;;=3^US For Residual Urine
 ;;^UTILITY(U,$J,358.3,40592,0)
 ;;=51727^^150^1975^1^^^^1
 ;;^UTILITY(U,$J,358.3,40592,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40592,1,2,0)
 ;;=2^51727
 ;;^UTILITY(U,$J,358.3,40592,1,3,0)
 ;;=3^CMG,Comp w/ UP Study
 ;;^UTILITY(U,$J,358.3,40593,0)
 ;;=51728^^150^1975^2^^^^1
 ;;^UTILITY(U,$J,358.3,40593,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40593,1,2,0)
 ;;=2^51728
 ;;^UTILITY(U,$J,358.3,40593,1,3,0)
 ;;=3^CMG,Comp w/ VP
 ;;^UTILITY(U,$J,358.3,40594,0)
 ;;=51729^^150^1975^3^^^^1
 ;;^UTILITY(U,$J,358.3,40594,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40594,1,2,0)
 ;;=2^51729
 ;;^UTILITY(U,$J,358.3,40594,1,3,0)
 ;;=3^CMG,Comp w/ VP & UP
 ;;^UTILITY(U,$J,358.3,40595,0)
 ;;=51736^^150^1975^12^^^^1
 ;;^UTILITY(U,$J,358.3,40595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40595,1,2,0)
 ;;=2^51736
 ;;^UTILITY(U,$J,358.3,40595,1,3,0)
 ;;=3^Uroflow,Simple
 ;;^UTILITY(U,$J,358.3,40596,0)
 ;;=51784^^150^1975^7^^^^1
 ;;^UTILITY(U,$J,358.3,40596,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40596,1,2,0)
 ;;=2^51784
 ;;^UTILITY(U,$J,358.3,40596,1,3,0)
 ;;=3^EMG Non-Needle
 ;;^UTILITY(U,$J,358.3,40597,0)
 ;;=J9202^^150^1976^33^^^^3
 ;;^UTILITY(U,$J,358.3,40597,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40597,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,40597,1,3,0)
 ;;=3^Zoladex 10.8 mg total
 ;;^UTILITY(U,$J,358.3,40598,0)
 ;;=96401^^150^1976^10^^^^1
 ;;^UTILITY(U,$J,358.3,40598,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40598,1,2,0)
 ;;=2^96401
 ;;^UTILITY(U,$J,358.3,40598,1,3,0)
 ;;=3^Chemotherapy,IM/SQ
 ;;^UTILITY(U,$J,358.3,40599,0)
 ;;=96402^^150^1976^19^^^^1
 ;;^UTILITY(U,$J,358.3,40599,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40599,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,40599,1,3,0)
 ;;=3^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,40600,0)
 ;;=96372^^150^1976^1^^^^1
 ;;^UTILITY(U,$J,358.3,40600,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40600,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,40600,1,3,0)
 ;;=3^Administration of Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,40601,0)
 ;;=96374^^150^1976^18^^^^1
 ;;^UTILITY(U,$J,358.3,40601,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40601,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,40601,1,3,0)
 ;;=3^IV Push,Single Non-Chemo Drug
 ;;^UTILITY(U,$J,358.3,40602,0)
 ;;=51720^^150^1976^6^^^^1
 ;;^UTILITY(U,$J,358.3,40602,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40602,1,2,0)
 ;;=2^51720
 ;;^UTILITY(U,$J,358.3,40602,1,3,0)
 ;;=3^Bladder Instill Anticarc
 ;;^UTILITY(U,$J,358.3,40603,0)
 ;;=J0897^^150^1976^14^^^^1
 ;;^UTILITY(U,$J,358.3,40603,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40603,1,2,0)
 ;;=2^J0897
 ;;^UTILITY(U,$J,358.3,40603,1,3,0)
 ;;=3^Denosumab Inj 1 mg
 ;;^UTILITY(U,$J,358.3,40604,0)
 ;;=J1950^^150^1976^24^^^^1
 ;;^UTILITY(U,$J,358.3,40604,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40604,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,40604,1,3,0)
 ;;=3^Leuprolide Acetate Susp 3.75 mg
 ;;^UTILITY(U,$J,358.3,40605,0)
 ;;=J3489^^150^1976^35^^^^1
 ;;^UTILITY(U,$J,358.3,40605,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40605,1,2,0)
 ;;=2^J3489
 ;;^UTILITY(U,$J,358.3,40605,1,3,0)
 ;;=3^Zoledronic Acid 1 mg
 ;;^UTILITY(U,$J,358.3,40606,0)
 ;;=J3490^^150^1976^31^^^^1
 ;;^UTILITY(U,$J,358.3,40606,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40606,1,2,0)
 ;;=2^J3490
 ;;^UTILITY(U,$J,358.3,40606,1,3,0)
 ;;=3^Unclassified Biologics
 ;;^UTILITY(U,$J,358.3,40607,0)
 ;;=J9155^^150^1976^13^^^^1
 ;;^UTILITY(U,$J,358.3,40607,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40607,1,2,0)
 ;;=2^J9155
 ;;^UTILITY(U,$J,358.3,40607,1,3,0)
 ;;=3^Degarelix 1 mg
 ;;^UTILITY(U,$J,358.3,40608,0)
 ;;=J9217^^150^1976^25^^^^1
 ;;^UTILITY(U,$J,358.3,40608,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40608,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,40608,1,3,0)
 ;;=3^Leuprolide Acetate Susp 7.5 mg
 ;;^UTILITY(U,$J,358.3,40609,0)
 ;;=J9218^^150^1976^22^^^^1
 ;;^UTILITY(U,$J,358.3,40609,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40609,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,40609,1,3,0)
 ;;=3^Leuprolide Acetate 1 mg
 ;;^UTILITY(U,$J,358.3,40610,0)
 ;;=J9219^^150^1976^23^^^^1
 ;;^UTILITY(U,$J,358.3,40610,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40610,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,40610,1,3,0)
 ;;=3^Leuprolide Acetate Implant 65 mg
 ;;^UTILITY(U,$J,358.3,40611,0)
 ;;=J0270^^150^1976^2^^^^1
 ;;^UTILITY(U,$J,358.3,40611,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40611,1,2,0)
 ;;=2^J0270
 ;;^UTILITY(U,$J,358.3,40611,1,3,0)
 ;;=3^Alprostadil 1.25 mcg
 ;;^UTILITY(U,$J,358.3,40612,0)
 ;;=J0275^^150^1976^3^^^^1
 ;;^UTILITY(U,$J,358.3,40612,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40612,1,2,0)
 ;;=2^J0275
 ;;^UTILITY(U,$J,358.3,40612,1,3,0)
 ;;=3^Alprostadil Urethral Suppository
 ;;^UTILITY(U,$J,358.3,40613,0)
 ;;=J2370^^150^1976^28^^^^1
 ;;^UTILITY(U,$J,358.3,40613,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40613,1,2,0)
 ;;=2^J2370
 ;;^UTILITY(U,$J,358.3,40613,1,3,0)
 ;;=3^Phenyleprhine HCL 1 mg
 ;;^UTILITY(U,$J,358.3,40614,0)
 ;;=J1212^^150^1976^11^^^^1
 ;;^UTILITY(U,$J,358.3,40614,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40614,1,2,0)
 ;;=2^J1212
 ;;^UTILITY(U,$J,358.3,40614,1,3,0)
 ;;=3^DMSO per 50 ml
 ;;^UTILITY(U,$J,358.3,40615,0)
 ;;=J9031^^150^1976^5^^^^1
 ;;^UTILITY(U,$J,358.3,40615,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40615,1,2,0)
 ;;=2^J9031
 ;;^UTILITY(U,$J,358.3,40615,1,3,0)
 ;;=3^BCG Intravesical per Instillation
